跳至主要内容
临床试验/NL-OMON36766
NL-OMON36766已完成不适用

In depth characterization of the mucosal microbiota in patients with IBD using novel, potent high-throughput approaches and their interaction with the immune system - Microbiota and immune cells in IBD

Academisch Medisch Centrum0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • *18 year old male or female, able to give informed consent
  • Established Crohn*s disease or ulcerative colitis (according to the Lennard-Jones criteria), or patients scheduled for diverting ostomy due to IBD.
  • control patients: patients who undergo intestinal resection due to a gastrointestinal malignancy

排除标准

  • Ischemia of the bowel
  • Positive stool cultures or parasite tests for common enteric pathogens (with exeption of non pathogenic parasites such as Blastocystis hominis or Endolimax nana)
  • Use of Antiobiotics in preceding 4 weeks
  • use of probiotics in preceding 8 weeks

研究者

相似试验